Switching From a Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen: A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy–suppressed Human Immunodeficiency Virus–infected Individuals

with No hi ha comentaris

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *